A laboratory study found that the 501Y.V2 variant achieved „complete escape“ from monoclonal antibodies, the man-made proteins that act like the antibodies produced by jabs.
Boris Johnson said he was holding „intensive talks“ with scientists about the new variants. The Prime Minister told MPs he was confident that the Medicines and Healthcare products Regulatory Agency (MHRA) was capable of approving new vaccine modifications as quickly as necessary.